Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma

Status unconfirmed · Not applicable

Conditions studied: Renal Cell Carcinoma

In brief

The aim of this study is to determine the utility of renal ultrasonography (US) in the detection of abdominal recurrences after definitive therapy for renal cell carcinoma (RCC) and compare the detection rate to that of cross-sectional imaging.

Key facts

Study ID

NCT04424472

Run by

University of Kansas Medical Center

People needed

50

Starts

2020-07-17

Expected to finish

2022-12-01

Last updated by the study team

2020-09-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be 18 year of age or older.
• Patients having undergone radical or partial nephrectomy for the indication of renal cell carcinoma.
• Most recent imaging study must have been either computed tomography (CT) or magnetic resonance imaging (MRI).

You may not qualify if…

• Patients with pT4 disease (tumor invades beyond the Gerota fascia: including contiguous extension into the ipsilateral adrenal gland).
• Patients with metastatic disease prior to time of surgery requiring systemic treatment.
• Patients with another active cancer diagnosis requiring systemic treatment.
• Patients with contrast allergies.
• Patients with baseline chronic kidney disease (GFR < 45 ml/min/1.73 m2).

Where it is running

• University of Kansas Health System — Kansas City, Kansas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.